News | July 22, 2007

Teleflex to Acquire Arrow International in $2.0 Billion Transaction

July 23, 2007 - Teleflex Inc., a global supplier of disposable medical products used in critical care, specialty medical, and surgical applications and Arrow International Inc. announced today that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.
The merger agreement, which was unanimously approved by both companies' Boards of Directors, provides for a cash payment of $45.50 per share for each outstanding share of Arrow stock, representing a premium of 20 percent over Arrow's closing share price on July 20, 2007.
"With the execution of this merger agreement, Teleflex is redefining its portfolio and its Medical Segment by creating a $1.4 billion medical technology business that will be the largest source of the company's revenues and profitability," said Jeffrey P. Black, Chairman of the Board and Chief Executive Officer of Teleflex. "With the addition of Arrow, we expect that by fiscal 2008 the Medical Segment should achieve annual revenues of approximately $1.5 billion and generate operating margins in the 20 percent range. We expect the transaction to be meaningfully accretive to Teleflex's earnings by 2009."
For more information: www.teleflex.com, http://www.arrowintl.com


Related Content

News | Intra-Aortic Balloon Pumps (IABP)

August 14, 2023 — The FDA has announced that Datascope/Maquet/Getinge is recalling the Cardiosave Hybrid and Rescue ...

Home August 14, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

Home May 19, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

March 31, 2023 — According to statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home March 31, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

March 20, 2023 — According to a statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home March 20, 2023
Home
News | Intra-Aortic Balloon Pumps (IABP)

January 25, 2023 — According to a new release from the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

Home January 25, 2023
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

Home December 20, 2022
Home
News | Intra-Aortic Balloon Pumps (IABP)

October 26, 2022 — Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved ...

Home October 26, 2022
Home
News | Intra-Aortic Balloon Pumps (IABP)

December 16, 2021 — Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic ...

Home December 16, 2021
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) ...

Home November 02, 2021
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all intra-aortic balloon ...

Home July 24, 2019
Home
Subscribe Now